Cellectis
CLLS
#7753
Rank
โ‚ฌ0.30 B
Marketcap
3,00ย โ‚ฌ
Share price
0.28%
Change (1 day)
90.90%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚ฌ0.30 Billion

As of February 2026 Cellectis has a market cap of โ‚ฌ0.30 Billion. This makes Cellectis the world's 7753th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.30 B-24.47%
2025โ‚ฌ0.40 B193.47%
2024โ‚ฌ0.13 B-30.69%
2023โ‚ฌ0.19 B118.61%
2022โ‚ฌ91.23 M-73.03%
2021โ‚ฌ0.33 B-67.37%
2020โ‚ฌ1.03 B55.69%
2019โ‚ฌ0.66 B4.07%
2018โ‚ฌ0.63 B-23.84%
2017โ‚ฌ0.84 B45.93%
2016โ‚ฌ0.57 B-41.39%
2015โ‚ฌ0.98 B172.75%
2014โ‚ฌ0.36 B642.67%
2013โ‚ฌ48.48 M

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Cellectis was reported to be:

โ‚ฌ0.21 Billion
by Nasdaq info icon info icon
โ‚ฌ0.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ69.61 B 22,619.18%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚ฌ1.40 B 359.12%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚ฌ1.13 B 271.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ0.38 B 26.93%๐Ÿ‡บ๐Ÿ‡ธ USA